Source comparison
Sermorelin ipamorelin vs CJC-1295 ipamorelin
The ipamorelin vs CJC-1295 comparison is one of the most common in peptide research circles. Both combinations pair ipamorelin with a GHRH-pathway peptide, but they have different characteristics. CJC-1295 comes in two forms: with DAC (Drug Affinity Complex) a
This comparison does not assign a generated winner or score.
- The ipamorelin vs CJC-1295 comparison is one of the most common in peptide research circles. Both combinations pair ipamorelin with a GHRH-pathway peptide, but they have different characteristics.
- CJC-1295 comes in two forms: with DAC (Drug Affinity Complex) and without DAC (also called modified GRF 1-29). The version with DAC has a dramatically extended half-life of 6-8 days, meaning it provides sustained GH elevation from a single injection. Without DAC, the half-life is similar to sermorelin.
- Key differences:
- Half-life: Sermorelin has a half-life of 10-20 minutes. CJC-1295 with DAC has a half-life of 6-8 days. This means sermorelin creates acute GH pulses while CJC-1295 with DAC creates sustained elevation.
- Injection frequency: Sermorelin requires daily injections for optimal effect. CJC-1295 with DAC can be injected 1-2 times per week.
- Pattern of GH release: Sermorelin produces more natural, pulsatile GH release patterns. CJC-1295 with DAC creates more constant elevation, which some argue is less physiological.
- FDA history: Sermorelin has FDA approval (though limited to specific indications). CJC-1295 has never been FDA-approved for any indication.
- Many practitioners prefer the sermorelin ipamorelin combination because it more closely mimics natural GH secretion patterns. The daily injections, while requiring more commitment, may produce more physiological results long-term.
- Our detailed CJC-1295 guide covers this peptide comprehensively.